CXCR6 and neoplasm: Analysis of endpoint tumors from mice that were treated with OT1+Mrb OVA showed that CXCR6 expression was seen predominantly in tumor-specific CD90.1+ OT1 (figure 3C), but less frequently in CD90.1− CD8+ T cells.